METHODES ET UTILISATIONS DE L'ALPHA-1 ANTI-TRYPSINE, OU DE SES FORMES RECOMBINEES, SUR UNE MALADIE DU GREFFON CONTRE L'HOTE, REFRACTAIRE AUX STEROIDES, IMPLIQUANT DES COMPLICATIONS GASTRO-INTESTINALES
THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE;FRED HUTCHINSON CANCER RESEARCH CENTER
发明人:
DINARELLO, CHARLES,MARCONDES, MARIO Q.,DEEG, H. JOACHIM
申请号:
CA3048613
公开号:
CA3048613A1
申请日:
2016.12.30
申请国别(地区):
CA
年份:
2017
代理人:
摘要:
Embodiments described herein relate to treating a subject with advanced-stage GvHD with a1-antitrypsin (AAT) or carboxyterminal peptide derivatives thereof or recombinant thereof. In certain embodiments, a subject can include a glucocorticoid-refractory patient having GvHD with gut involvement. In other embodiments, donor subjects of a transplant can be treated with a1-antitrypsin (AAT) or carboxyterminal peptide derivatives thereof or recombinant thereof to reduce graft rejection or GvhD in a recipient subject.